نتایج جستجو برای: sars cov 2

تعداد نتایج: 2534203  

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spilled over to humans via wild mammals, entering the host cell using angiotensin-converting enzyme 2 (ACE2) as receptor through Spike (S) protein binding. While SARS-CoV-2 became fully adapted to humans and globally spread, some mammal species were infected back. The present study evaluated the potential risk of mammals...

2010
Janet Raboud Altynay Shigayeva Allison McGeer Erika Bontovics Martin Chapman Denise Gravel Bonnie Henry Stephen Lapinsky Mark Loeb L. Clifford McDonald Marianna Ofner Shirley Paton Donna Reynolds Damon Scales Sandy Shen Andrew Simor Thomas Stewart Mary Vearncombe Dick Zoutman Karen Green

BACKGROUND In the 2003 Toronto SARS outbreak, SARS-CoV was transmitted in hospitals despite adherence to infection control procedures. Considerable controversy resulted regarding which procedures and behaviours were associated with the greatest risk of SARS-CoV transmission. METHODS A retrospective cohort study was conducted to identify risk factors for transmission of SARS-CoV during intubat...

Journal: :The Biochemical journal 2005
Yu Yang Zeyu Xiong Sheng Zhang Yan Yan Justin Nguyen Bernard Ng Huifang Lu John Brendese Fan Yang Hong Wang Xiao-Feng Yang

One of the hallmark findings in patients suffering from SARS (severe acute respiratory syndrome) is lymphopenia, which is the result of massive lymphocyte death. SARS-CoV (SARS coronavirus), a novel coronavirus that has been etiologically associated with SARS cases, is homologous with MHV (murine hepatitis coronavirus), and MHV small envelope E protein is capable of inducing apoptosis. We hypot...

Journal: :The Journal of general virology 2005
Shuetsu Fukushi Tetsuya Mizutani Masayuki Saijo Shutoku Matsuyama Naoko Miyajima Fumihiro Taguchi Shigeyuki Itamura Ichiro Kurane Shigeru Morikawa

Severe acute respiratory syndrome coronavirus (SARS-CoV) contains a single spike (S) protein, which binds to its receptor, angiotensin-converting enzyme 2 (ACE2), induces membrane fusion and serves as a neutralizing antigen. A SARS-CoV-S protein-bearing vesicular stomatitis virus (VSV) pseudotype using the VSVDeltaG* system was generated. Partial deletion of the SARS-CoV-S protein cytoplasmic d...

Journal: :Journal of virology 2013
Adeyemi O Adedeji William Severson Colleen Jonsson Kamalendra Singh Susan R Weiss Stefan G Sarafianos

Severe acute respiratory syndrome (SARS) is an infectious and highly contagious disease that is caused by SARS coronavirus (SARS-CoV) and for which there are currently no approved treatments. We report the discovery and characterization of small-molecule inhibitors of SARS-CoV replication that block viral entry by three different mechanisms. The compounds were discovered by screening a chemical...

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2012
M Jaume M S Yip Y W Kam C Y Cheung F Kien A Roberts P H Li I Dutry N Escriou M Daeron R Bruzzone K Subbarao J S M Peiris B Nal R Altmeyer

1. A SARS vaccine was produced based on recombinant native full-length Spike-protein trimers (triSpike) and efficient establishment of a vaccination procedure in rodents. 2. Antibody-mediated enhancement of SARS-CoV infection with anti-SARS-CoV Spike immune-serum was observed in vitro. 3. Antibody-mediated infection of SARS-CoV triggers entry into human haematopoietic cells via an FcγR-dependen...

Journal: :Viral immunology 2008
Weiwei Gai Wei Zou Lei Lei Junyi Luo Haobo Tu Yan Zhang Kai Wang Po Tien Huimin Yan

Severe acute respiratory syndrome (SARS) is a deadly and highly infectious disease caused by SARS Coronavirus (SARS-CoV). Inactivated SARS-CoV has been explored as a vaccine against SARS-CoV; however, current knowledge of inactivated SARS-CoV vaccine is quite limited. We attempted to investigate the effects of different immunization protocols and adjuvant on the antibody responses to inactivate...

2012
Mark J. Cameron Alyson A. Kelvin Alberto J. Leon Cheryl M. Cameron Longsi Ran Luoling Xu Yong-Kyu Chu Ali Danesh Yuan Fang Qianjun Li Austin Anderson Ronald C. Couch Stephane G. Paquette Ndingsa G. Fomukong Otfried Kistner Manfred Lauchart Thomas Rowe Kevin S. Harrod Colleen B. Jonsson David J. Kelvin

In terms of its highly pathogenic nature, there remains a significant need to further define the immune pathology of SARS-coronavirus (SARS-CoV) infection, as well as identify correlates of immunity to help develop vaccines for severe coronaviral infections. Here we use a SARS-CoV infection-reinfection ferret model and a functional genomics approach to gain insight into SARS immunopathogenesis ...

2012
Sjoerd H. E. van den Worm Klara Kristin Eriksson Jessika C. Zevenhoven Friedemann Weber Roland Züst Thomas Kuri Ronald Dijkman Guohui Chang Stuart G. Siddell Eric J. Snijder Volker Thiel Andrew D. Davidson

Severe acute respiratory syndrome (SARS) is a zoonotic disease caused by SARS-related coronavirus (SARS-CoV) that emerged in 2002 to become a global health concern. Although the original outbreak was controlled by classical public health measures, there is a real risk that another SARS-CoV could re-emerge from its natural reservoir, either in its original form or as a more virulent or pathogeni...

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2012
K K B Li C W Yip C C Hon C Y Lam F Zeng F C C Leung

1. Comprehensive surveillance of civets, mice, cats, Golden Syrian hamsters, and horseshoe bats is suggested when SARS or SARS-like CoVs re-emerge in the human population in the future. 2. Rabbits and horseshoe bats are animal carriers of SARS-CoV. 3. Investigation of the genetic diversity of CoV in two bat species (Rhinolophus sinicus and Rhinolophus pearsonii) should provide insights into the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید